| Literature DB >> 28642745 |
A A Hassan1, Rita F Maldonado1, Sandra C Dos Santos1, Flaviana Di Lorenzo2, Alba Silipo2, Carla P Coutinho1, Vaughn S Cooper3, Antonio Molinaro2, Miguel A Valvano4, Isabel Sá-Correia1.
Abstract
Burkholderia cenocepacia is an opportunistic pathogen associated with chronic lung infections and increased risk of death in patients with cystic fibrosis (CF). In this work, we investigated the lipopolysaccharide (LPS) of clinical variants of B. cenocepacia that were collected from a CF patient over a period of 3.5 years, from the onset of infection until death by necrotizing pneumonia (cepacia syndrome). We report the chemical structure of the LPS molecule of various sequential isolates and the identification of a novel hybrid O-antigen (OAg) biosynthetic cluster. The OAg repeating unit of the LPS from IST439, the initial isolate, is a [→2)-β-D-Ribf-(1→4)-α-D-GalpNAc-(1→] disaccharide, which was not previously described in B. cenocepacia. The IST439 OAg biosynthetic gene cluster contains 7 of 23 genes that are closely homologous to genes found in B. multivorans, another member of the Burkholderia cepacia complex. None of the subsequent isolates expressed OAg. Genomic sequencing of these isolates enabled the identification of mutations within the OAg cluster, but none of these mutations could be associated with the loss of OAg. This study provides support to the notion that OAg LPS modifications are an important factor in the adaptation of B. cenocepacia to chronic infection and that the heterogeneity of OAgs relates to variation within the OAg gene cluster, indicating that the gene cluster might have been assembled through multiple horizontal transmission events.Entities:
Keywords: Burkholderia cepacia complex; O-antigen; chronic infection; clonal variation; cystic fibrosis; lipopolysaccharide
Year: 2017 PMID: 28642745 PMCID: PMC5462993 DOI: 10.3389/fmicb.2017.01027
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Description of Burkholderia isolates and E. coli strains used in this study.
| Bacterial isolate | Isolation date | Species | Description |
|---|---|---|---|
| IST419 | 2/26/1998 | Clinical isolates obtained from a chronically infected patient followed at the Cystic Fibrosis | |
| IST439 | 1/30/1999 | Center of Hospital Santa Maria, Lisbon, Portugal ( | |
| IST4103 | 7/24/2001 | ||
| IST4110 | 9/25/2001 | ||
| IST4112 | 10/11/2001 | ||
| IST4113 | 11/6/2001 | ||
| IST4116A | 2/11/2002 | ||
| IST4116B | 2/11/2002 | ||
| IST4131 | 2/26/2002 | ||
| IST4129 | 3/26/2002 | ||
| IST4130 | 5/14/2002 | ||
| IST4134 | 7/2/2002 | ||
| ATCC 17616 | Soil isolate (Berkeley, CA, United States) ( | ||
| DH5-α (pRK2013) | Helper strain for triparental conjugation ( | ||
| ER2925 (dam- dcm-) | Host for plasmids used to transform resilient |
Chemical shift δ (1H/13C) of the O-chain moiety from B. cenocepacia IST439.
| A | 5.09 | 4.15 | 4.03 | 3.95 | 3.77–3.59 | – |
| 2-β-Rib | 106.6 | 78.7 | 67.2 | 82.3 | 62.5 | – |
| B | 4.99 | 4.02 | 3.93 | 3.61 | 3.63 | 4.03 |
| 4-α-GalNAc | 95.5 | 50.0 | 76.2 | 78.9 | 60.5 | 70.8 |